Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950123-22-003670
Filing Date
2022-03-30
Accepted
2022-03-30 09:05:23
Documents
11
Period of Report
2022-05-10

Document Format Files

Seq Description Document Type Size
1 DEF 14A mnkd-def14a_20220510.htm DEF 14A 1866840
2 GRAPHIC g3fpau1molud000001.jpg GRAPHIC 578361
3 GRAPHIC g3fpau1molud000002.jpg GRAPHIC 14124
4 GRAPHIC g3fpau1molud000003.jpg GRAPHIC 894
5 GRAPHIC g3fpau1molud000004.jpg GRAPHIC 14124
6 GRAPHIC g3fpau1molud000005.jpg GRAPHIC 11608
7 GRAPHIC g3fpau1molud000006.jpg GRAPHIC 83335
8 GRAPHIC g3fpau1molud000007.jpg GRAPHIC 84117
9 GRAPHIC g3fpau1molud000008.jpg GRAPHIC 11608
10 GRAPHIC g3fpau1molud000009.jpg GRAPHIC 60275
11 GRAPHIC g3fpau1molud000010.jpg GRAPHIC 47996
  Complete submission text file 0000950123-22-003670.txt   3117726
Mailing Address 1 CASPER STREET DANBURY CT 06810
Business Address 1 CASPER STREET DANBURY CT 06810 818-661-5000
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

EIN.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-50865 | Film No.: 22783455
SIC: 2834 Pharmaceutical Preparations